SCHEMBL26259256

SCHEMBL26259256

Cc1ccc2c(-c3cccs3)c(C)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 4/20 0.50
HPGD P15428 3/20 0.50
LMNA P02545 2/20 0.50
HSD17B10 Q99714 2/20 0.50
GAA P10253 1/20 0.50
CYP1A2 P05177 4/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
MAPT P10636 5/20 0.40
DHFR P00374 1/20 0.40
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CYP2A6 P11509 4/20 0.38
TDP1 Q9NUW8 1/20 0.37
TP53 P04637 3/20 0.37
TSHR P16473 2/20 0.37
ADK P55263 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259597 0.82 ACHE (0.42) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL26259245 0.81 CYP2A6 (0.47) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL12664820 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNACYP1A2
SCHEMBL13044266 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNACYP1A2
SCHEMBL26259430 0.76 MAOA (0.43) ALDH1A1KDM4EHPGDLMNAMAOA
SCHEMBL26259584 0.73 KDM4E (0.40) ALDH1A1KDM4EHPGDGAAMAPT
SCHEMBL15274508 0.73 PGR (0.51) ALDH1A1KDM4EHPGDLMNACYP1A2
SCHEMBL26259259 0.72 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDLMNAHSD17B10
SCHEMBL1284670 0.72 MAOA (0.50) ALDH1A1KDM4EHPGDLMNAMAOA
SCHEMBL2966615 0.71 RAB9A (0.42) ALDH1A1KDM4EHPGDLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 ALDH1A1 2125/4885KDM4E 1663/4885HPGD 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.